Exane Derivatives’s Ameren AEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,481
Closed -$233K 769
2022
Q1
$233K Sell
2,481
-835
-25% -$73.1K 0.07% 296
2021
Q4
$295K Sell
3,316
-99
-3% -$8.41K 0.07% 263
2021
Q3
$277K Buy
3,415
+481
+16% +$41K 0.07% 307
2021
Q2
$242K Buy
+2,934
New +$246K 0.06% 350

Other funds holding AEE

Exane Derivatives's AEE Position: Q2 2022 in Review

Exane Derivatives sold out of Ameren (AEE) in Q2 2022, closing a stake of 2,481 shares — an estimated $233K sold.

Exane Derivatives first reported a position in AEE in Q2 2021 and held it in 4 quarters. The position peaked at $295K in Q4 2021. 663 funds tracked by Wall St. Rank hold AEE as of Q2 2022.

  • Exane Derivatives reported no remaining Ameren position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 2,481 Ameren shares in Q2 2022, an estimated $233K.
  • Exane Derivatives first reported a position in Ameren in Q2 2021 and held it in 4 quarters.
  • Exane Derivatives's Ameren position peaked at $295K in Q4 2021.
  • 663 funds tracked by Wall St. Rank held Ameren as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.